| 0.5 |
1.4 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
| 0.4 |
1.7 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.4 |
1.9 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 0.4 |
0.4 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.3 |
1.0 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 0.3 |
0.9 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 |
0.8 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.3 |
0.8 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.3 |
0.8 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
1.5 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.3 |
1.3 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) |
| 0.2 |
1.0 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 |
1.9 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.2 |
0.7 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.2 |
0.5 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
1.0 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
0.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
0.9 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
0.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.4 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.1 |
1.6 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
0.9 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.0 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.7 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.4 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.1 |
1.9 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
1.2 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.2 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.1 |
0.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 |
0.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.4 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.1 |
0.2 |
GO:1900377 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 |
0.4 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.3 |
GO:0015920 |
regulation of phosphatidylcholine catabolic process(GO:0010899) lipopolysaccharide transport(GO:0015920) |
| 0.1 |
0.7 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.1 |
0.6 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
2.8 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.2 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.2 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.1 |
0.3 |
GO:0046864 |
retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 0.1 |
0.2 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.1 |
1.5 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.3 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.2 |
GO:1902071 |
regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.1 |
0.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.1 |
0.3 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
1.0 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.1 |
0.6 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) |
| 0.1 |
0.2 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
1.0 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.3 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.1 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.0 |
0.4 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.0 |
0.1 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
1.0 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.3 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.4 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 |
0.2 |
GO:1904017 |
positive regulation of female receptivity(GO:0045925) response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.0 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.2 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.9 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.0 |
0.1 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.0 |
0.0 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.5 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 |
0.8 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
0.7 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.1 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.0 |
0.4 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 |
0.3 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.7 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.0 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.0 |
0.1 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.0 |
1.1 |
GO:0045580 |
regulation of T cell differentiation(GO:0045580) |
| 0.0 |
0.1 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
